FI942392A0 - Peptidejä ja vasta-aineita nivelreuman hoitoon - Google Patents

Peptidejä ja vasta-aineita nivelreuman hoitoon

Info

Publication number
FI942392A0
FI942392A0 FI942392A FI942392A FI942392A0 FI 942392 A0 FI942392 A0 FI 942392A0 FI 942392 A FI942392 A FI 942392A FI 942392 A FI942392 A FI 942392A FI 942392 A0 FI942392 A0 FI 942392A0
Authority
FI
Finland
Prior art keywords
peptides
antibodies
treatment
rheumatoid arthritis
necessarily adjacent
Prior art date
Application number
FI942392A
Other languages
English (en)
Swedish (sv)
Other versions
FI942392A (fi
Inventor
Julian Kirby
Ian Victor Lewin
Sarita Maman
Denis Raymond Stanworth
Original Assignee
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Therapeutics Ltd filed Critical Peptide Therapeutics Ltd
Publication of FI942392A0 publication Critical patent/FI942392A0/fi
Publication of FI942392A publication Critical patent/FI942392A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
FI942392A 1991-11-25 1994-05-24 Peptidejä ja vasta-aineita nivelreuman hoitoon FI942392A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919125024A GB9125024D0 (en) 1991-11-25 1991-11-25 Rheumatoid arthritus treatment
PCT/GB1992/002174 WO1993011153A1 (en) 1991-11-25 1992-11-25 Peptides and antibodies for treatment of rheumatoid arthritis

Publications (2)

Publication Number Publication Date
FI942392A0 true FI942392A0 (fi) 1994-05-24
FI942392A FI942392A (fi) 1994-05-24

Family

ID=10705197

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942392A FI942392A (fi) 1991-11-25 1994-05-24 Peptidejä ja vasta-aineita nivelreuman hoitoon

Country Status (10)

Country Link
EP (1) EP0614464B1 (fi)
JP (1) JPH07507045A (fi)
AT (1) ATE163939T1 (fi)
AU (2) AU2951392A (fi)
CA (1) CA2123694A1 (fi)
DE (1) DE69224750D1 (fi)
ES (1) ES2112921T3 (fi)
FI (1) FI942392A (fi)
GB (2) GB9125024D0 (fi)
WO (1) WO1993011153A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416864D0 (en) * 1994-08-19 1994-10-12 Peptide Therapeutrics Limited Treatment of IgA nephropathy
GB9416865D0 (en) * 1994-08-19 1994-10-12 Peptide Therapeutrics Limited Treatment of inflammatory diseases of the gastro-intestinal tract
ES2190799T5 (es) 1996-03-01 2008-08-16 Novartis Ag Inmunogenos peptidicos para vacunacion y tratamiento contra la alergia.
WO2001098540A2 (en) * 2000-06-22 2001-12-27 San Diego State University Foundation Recombination modulators and methods for their production and use
WO2009158432A2 (en) 2008-06-27 2009-12-30 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis
US11918624B2 (en) 2020-06-10 2024-03-05 Kelsius Laboratories LLC Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
AU572173B2 (en) * 1983-08-29 1988-05-05 Institut De Recherches Cliniques De Montreal Natriuretic factors
US4701416A (en) * 1983-12-09 1987-10-20 Cetus Corporation Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV
US4692511A (en) * 1984-07-03 1987-09-08 Immunetech Pharmaceuticals Peptide antagonists for the C5a anaphylatoxin
CA1327096C (en) * 1985-12-26 1994-02-15 Marta I. Sabara Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses
GB8616174D0 (en) * 1986-07-02 1986-08-06 Antibody Technology Ltd Monoclonal antibodies
DK268889A (da) * 1988-06-07 1989-12-08 Smithkline Beckman Corp Cykliske d-cys6-peptidforbindelser, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
DE346022T1 (de) * 1988-06-10 1990-05-23 Medical Research Council, London, Gb Peptidfragmente von hiv.
FR2646425B1 (fr) * 1989-04-26 1991-08-30 Neosystem Sa Peptides synthetiques du conjugue de l'ubiquitine et de l'histone h2a
JP3058685B2 (ja) * 1989-05-08 2000-07-04 アイデックス ラボラトリーズ インコーポレーテッド ネコｔ細胞リンパトロピック レンチウィルスのポリペプチド
JPH05508835A (ja) * 1990-05-25 1993-12-09 ペプチド・セラピューティクス・リミテッド 慢性関節リウマチの免疫診断検定法
CA2060699A1 (en) * 1991-02-11 1992-08-12 Isia Bursuker Gm-csf inhibiting oligopeptides

Also Published As

Publication number Publication date
AU7196596A (en) 1997-02-06
JPH07507045A (ja) 1995-08-03
WO1993011153A1 (en) 1993-06-10
EP0614464B1 (en) 1998-03-11
GB2261665B (en) 1995-11-08
DE69224750D1 (de) 1998-04-16
FI942392A (fi) 1994-05-24
ES2112921T3 (es) 1998-04-16
GB2261665A (en) 1993-05-26
EP0614464A1 (en) 1994-09-14
ATE163939T1 (de) 1998-03-15
GB9224684D0 (en) 1993-01-13
CA2123694A1 (en) 1993-06-10
GB9125024D0 (en) 1992-01-22
AU2951392A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
ATE442159T1 (de) Parathyroidhormon analoge
DK156592A (da) Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin
DE69129865T2 (de) Osteogene peptide
ES2174770T1 (es) Peptidos diseñados para el diagnostico y el tratamiento de artritis reumatoide.
ES548617A0 (es) Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo
ES2140390T3 (es) Metodos para la trans-desestabilizacion de proteinas in vivo.
AU5446590A (en) Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions
DE69525544T2 (de) Peptidanaloga des menschlichen myelinbasischen proteins mit substitution in position 91 zur behandlung von multipler sklerose
SE9403526D0 (sv) New Peptides
ES2172044T3 (es) Supresion de la proliferacion de celulas t usando fragmentos peptidicos de proteina basica de mielina.
FI942392A0 (fi) Peptidejä ja vasta-aineita nivelreuman hoitoon
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
ES2094160T3 (es) Peptidos terapeuticos, en particular analogos del peptido substancia p.
ES2087337T3 (es) Composiciones de implantes que contienen una proteina, peptido o polipeptido biologicamente activos.
DE69027542D1 (de) Solubilisierung und reinigung des rezeptors für das gastrin-freisetzende peptid
DK34590A (da) Biologisk aktive molekyler
ATE92078T1 (de) Pharmakologisch aktive peptide.
ES2080326T3 (es) Proteinas similares a ancrod, su obtencion y empleo.
DK0423326T3 (da) Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta
ES2114004T3 (es) Procedimiento de preparacion de peptidos con un residuo prolina amidado en la posicion c-terminal.
SE9100284D0 (sv) Novel peptide
JPS5775960A (en) Purified polypeptide
ES2112311T3 (es) Vacuna acelular.
DK53290A (da) Syntetiske gaer-leader-peptider
DK119391A (da) Humaninsulinanaloger